Search Results
49 Results for 'Diagnostics & Biomarkers'
PAGE 1 OF 2
Technology
Single-Domain Antibodies And Variants Thereof Against Met
UW-Madison researchers have developed a novel camelid antibody against the cancer target cMET. As cMET is overexpressed on many tumors, this antibody may be useful for imaging tumors and/or delivering...
Learn More
Learn More
Andrew Baschnagel, Randall Kimple, Reinier Hernandez, Aaron LeBeau | P230175US02
Technology
Methods for Enriching Microbial Cell-Free DNA in Plasma
UW-Madison researchers have developed a method of enriching microbial DNA in a plasma DNA sample for early detection of microbial infection. Previously, this group found that microbial DNA fragments a...
Learn More
Learn More
Mehreen Kisat, Bradon McDonald, Eddie Dominguez | P230447US02
Technology
Monoclonal Antibodies Targeting Ketamine and Its Metabolites
UW-Madison researchers have developed monoclonal antibodies to ketamine and monoclonal antibodies to 6-HNK, one of the major metabolites of ketamine. The antibodies are selective enough to bind to the...
Learn More
Learn More
Cody Wenthur, Jillian Kyzer, Natalie Gonzalez Velazquez, Uriel Enriquez | P240365US01
Technology
Analysis of Fragment Ends in DNA
UW-Madison researchers have developed a method of diagnosing cancer through detection of specific fragmentation patterns of cell free DNA in plasma. Their approach is distinctly focused on positioning...
Learn More
Learn More
Muhammed Murtaza, Karan Budhraja | P230002US02
Technology
THE MIDBODY AND MIDBODY REMNANT ARE ASSEMBLY SITES FOR RNA AND ACTIVE TRANSLATION
UW-Madison researchers have discovered that the midbody (MB) functions as an RNA-based organelle with active translation activity, which serves as a novel means of RNA-based intercellular communicatio...
Learn More
Learn More
Ahna Skop, Sungjin Park, Smit Patel | P230134US02
Technology
cfDNA Fragmentomic Detection Of Cancer
UW-Madison researchers have developed a method of identifying and characterizing DNA fragmentation patterns in circulating tumor cells using targeted circulating tumor cell DNA (ctDNA) panels. These r...
Learn More
Learn More
Shuang Zhao, Kyle Helzer | P220310US03
Technology
A High Throughput Newborn Screening Assay For Angelman And Prader-Willi Syndromes
A UW researcher has developed a higher throughput method for detection of the methylation pattern of the alleles involved in Prader-Willi and Angelman disorders from dried blood spots. This method pro...
Learn More
Learn More
Mei Baker | P230235US02
Technology
NOVEL AUTO-ANTIBODIES AND METHOD TO DETECT SJÖGREN’S DISEASE
A UW-Madison researcher has developed a new diagnostic assay for Sjogren's syndrome, based on her discovery of novel autoantibodies relevant to the disease process. Using whole peptidome array tec...
Learn More
Learn More
Sara McCoy, Miriam Shelef, Michael Newton, Zihao Zheng | P220234WO01
Technology
IDENTIFYING DISEASE-CAUSING HUMAN DDX41 GENETIC VARIANTS
UW-Madison researchers have developed a genetic rescue assay that discriminates the activities of wild type DDX41 from those of human myeloid malignancy-associated germline and somatic DDX41 mutants. ...
Learn More
Learn More
Emery Bresnick, Jeong-Ah Kim | P230033US02
Technology
An Optimized, More Efficient Method for Characterizing Microorganisms and Viruses Using Metagenomics
Metagenomics is the study of genetic material from environmental samples for detecting microbes, especially pathogens. It is increasingly used within clinical and industrial settings. While metagenomi...
Learn More
Learn More
Tony Goldberg, Samuel Sibley | P160266US02
Technology
Fibroblast Activation ImmunoPET for Detection of Fibrosis Activity
UW-Madison researchers have developed a novel, cross-species antibody to fibroblast activation protein (FAP). The researchers identified the antibody through screening of a phage display library. That...
Learn More
Learn More
Reinier Hernandez, Aaron LeBeau, Zachary Rosenkrans, Chris Massey, Joseph Gallant | P220283US02
Technology
Developing Specific Rheumatoid Factors as Diagnostic and Therapeutic Tools
Rheumatoid factors (RFs) are antibodies that commonly develop in patients with rheumatoid arthritis (RA), an incurable autoimmune disease that affects ~1% of the population. RFs bind to IgG and other ...
Learn More
Learn More
Miriam Shelef | P220084US02
Technology
UNIVERSAL METHOD FOR PARASITE AND EUKARYOTIC ENDOSYMBIONT IDENTIFICATION
UW-Madison researchers have developed and validated a novel “parasitome” method to accurately characterize parasites in samples. Like published metabarcoding protocols, the new method consists of ...
Learn More
Learn More
Tony Goldberg, Leah Owens | P220194WO01
Technology
INFLUENZA VIRUS ISOLATE A/WISCONSIN/588/2019
Staff at the Wisconsin State Laboratory of Hygiene have prepared influenza virus isolate A/Wisconsin/588/2019 (FR-1758), as part of their influenza surveillance work through the national CDC-led influ...
Learn More
Learn More
Allen Bateman | P230354US01
Technology
High-Throughput Microfluidics Platform Enables Scalable Single-Cell Nucleic Acid Biomarker Detection
Detection of genetic aberrations using nucleic acids as biomarkers can be a powerful strategy for disease diagnosis and progression monitoring; however, the high heterogeneity of cells within a patien...
Learn More
Learn More
Philip Romero, Leland Hyman | P180094US02
Technology
T CELL SPECIFIC BIOMARKERS FOR PREDICTING GRAFT-VS-HOST DISEASE AND HEMATOPOIETIC MALIGNANCY RELAPSE FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION AND TREATMENT THEREOF
UW-Madison researchers have identified and validated a set of human T cell specific biomarkers that can predicti graft-vs-host disease (GVHD) and/or relapse following allogeneic hematopoietic stem cel...
Learn More
Learn More
Christian Capitini, Nicholas Hess, Kalyan Nadiminti, Peiman Hematti, Jenny Gumperz | P220161US02
Technology
AN ACCURATE AND COMPREHENSIVE CARDIAC TROPONIN I ASSAY ENABLED BY NANOTECHNOLOGY AND PROTEOMICS
UW-Madison researchers have developed mass spectrometry (MS) compatible nanoparticles for the selective capture and enrichment of low abundance proteins. The surface of superparamagnetic nanoparticles...
Learn More
Learn More
Ying Ge, Song Jin, Timothy-Neil Tiambeng, David Roberts | P190235US02
Technology
DETECTING, PREDICTING SEVERITY OF, AND/OR PREDICTING TREATMENT RESPONSE TO RESPIRATORY VIRUS INFECTION
Using two sets of comparative patient samples (hospitalized COVID-19 patients vs controls from 3 years ago, and hospitalized COVID-19 patients vs patients hospitalized for other conditions), the inven...
Learn More
Learn More
Reid Alisch, Kirk Hogan, Andy Madrid, Ariel Jaitovich | P210192US02
Technology
ANTI-GATA2 MONOCLONAL ANTIBODIES
UW-Madison researchers have developed three novel monoclonal antibodies that all have exceptional activity against human and mouse GATA2.
Learn More
Learn More
Emery Bresnick, Daniel Matson | P220242US01
Technology
IDENTIFICATION OF SARS-COV-2 EPITOPES DISCRIMINATING COVID-19 INFECTION FROM CONTROL AND METHODS OF USE
UW – Madison researchers have determined that SARS-CoV-2 infection induces antibodies against both structural and non-structural proteins and they identified epitopes in the SARS-CoV-2 membrane prot...
Learn More
Learn More
Irene Ong, David O'Connor, Miriam Shelef, Anna Heffron, David Baker, Maya Amjadi, Sean McIlwain, Saniya Khullar | P210048WO01
Technology
ONE-STEP SAMPLE EXTRACTION CASSETTE AND METHOD FOR POINT-OF-CARE MOLECULAR TESTING
The current gold standard method for COVID-19 testing is a multi-step protocol
25 involving RNA extraction using column-based or magnetic bead-based methods,
followed by RT-qPCR-based detection of the...
Learn More
Learn More
Duane Juang, Terry Juang, David Beebe | P210247US01
Technology
Image Analysis of Histologically Normal Prostate Biopsies Predicts Cancer Presence
Prostate cancer is the most commonly diagnosed disease in men. Current clinical practice for prostate cancer screening uses the prostate specific antigen (PSA) test. However, PSA-based screening detec...
Learn More
Learn More
David Jarrard, Bing Yang, Peter LaViolette | P190032US02
Technology
Toilet, Testing and Monitoring Systems
Systems for monitoring metabolites may include a sample collection system and a urinalysis system of or for a toilet. The sample collection system may be automated to collect sample urine from a toi...
Learn More
Learn More
Joshua Coon, Michael Westphall, Ian Miller, Lloyd Smith, Keaton Mertz | P200202WO01
Technology
Epigenetic Modification of Select Genes as Markers of Hypersomnolence
Differentially methylated positions associated with hypersomnolence, idiopathic hypersomnia, and long sleep time are provided herein along with biomarker panels thereof and methods of diagnosing and p...
Learn More
Learn More
David Plante, Reid Alisch | P200207WO01
Technology
Microbial Glycans As A Target Of Human Intelectin
The present disclosure provides for methods of diagnosing and treating bacterial infections. Human Intelectin 1 (hIntL-1) has been shown to bind selectively to glycan components on bacteria including ...
Learn More
Learn More
Laura Kiessling, Darryl Wesener, Kittikhun Wangkanont | P150027US02